OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

Oncology Business News®

home / publications / oncology-business-news
  • All
  • 2022
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • All
April 2022

Oncology Business News®: April 2022

Volume: 1

Issue: 1

View Issue
Download Issue
April 2018

April 2018

Download Issue
December 2017

December 2017

View Issue
November 2017

November 2017

View Issue
October 2017

October 2017

View Issue
September 2017

September 2017

View Issue
August 2017

August 2017

View Issue
July 2017

July 2017

View Issue
June 2017

June 2017

View Issue
May 2017

May 2017

View Issue
April 2017

April 2017

View Issue
March 2017

March 2017

View Issue
February 2017

February 2017

View Issue
January 2017

January 2017

View Issue
December 2016

December 2016

View Issue
November 2016

November 2016

View Issue
October 2016

October 2016

View Issue
September 2016

September 2016

View Issue
August 2016

August 2016

View Issue
July 2016

July 2016

View Issue
June 2016

June 2016

View Issue
May 2016

May 2016

Volume: 5

Issue: 5

View Issue
April 2016

April 2016

Volume: 5

Issue: 4

View Issue
March 2016

March 2016

Volume: 5

Issue: 3

View Issue
February 2016

February 2016

Volume: 5

Issue: 2

View Issue
January 2016

January 2016

Volume: 5

Issue: 1

View Issue
December 2015

December 2015

Volume: 4

Issue: 11

View Issue
November 2015

November 2015

Volume: 4

Issue: 10

View Issue
October 2015

October 2015

Volume: 4

Issue: 9

View Issue
September 2015

September 2015

Volume: 4

Issue: 8

View Issue
12>

Latest Conference Coverage

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment

First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma

Data for Luspatercept Highlight Evolving Treatment Landscape in Lower-Risk MDS

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact